Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Since 1989, a project at the KEMRI CRC Unit at Kilifi has focused on the design of appropriate and practicable regimens for the treatment of severe falciparum malaria. Initially, there was no data describing the absorption, distribution and elimination of quinine in Kenyan children, who constitute the great majority of patients. Pharmacokinetic studies were conducted to define these variables, which formed the basis for the design of appropriate and practicable treatment regimens. Even with optimal clinical management, the majority is high in cases of severe malaria treated with quinine at Kilifi. Alternative drugs have been studied in a search for a therapeutic regimen that will further reduce mortality.


Journal article


Afr J Health Sci

Publication Date





20 - 26